Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery

Carbohydrate Polymers

Volumn 92, Issue 1, 2013, Pages 57-62

  Park, Soyeon ^a   Jeong, Eun Ju ^a   Lee, Jangwook ^a   Rhim, Taiyoun ^a   Lee, Sang Kyung ^a   Lee, Kuen Yong ^a  

^a Hanyang University   (South Korea)

Author keywords

Chitosan; Gene delivery; Nonaarginine; siRNA

Indexed keywords

AMINO GROUP; ARGININE RESIDUE; CELLULAR ASSOCIATION; CELLULAR UPTAKE; CHITOSAN NANOPARTICLES; GENE DELIVERY; IN-VITRO; LOW LEVEL; LOW TOXICITY; MEAN DIAMETER; NONAARGININE; POSITIVELY CHARGED; SIRNA; SIRNA DELIVERY; TRANSFECTION EFFICIENCY;

AMINO ACIDS; GENE TRANSFER; MOLECULAR BIOLOGY; NANOPARTICLES; ZETA POTENTIAL;

CHITOSAN;

CHITOSAN; NANOPARTICLE; NONAARGININE; OLIGOPEPTIDE; SMALL INTERFERING RNA;

ARTICLE; CELL LINE; CHEMISTRY; GENE THERAPY; GENE TRANSFER; GENETICS; HELA CELL; HUMAN; PARTICLE SIZE; SYNTHESIS;

CELL LINE; CHITOSAN; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HELA CELLS; HUMANS; NANOPARTICLES; OLIGOPEPTIDES; PARTICLE SIZE; RNA, SMALL INTERFERING;

EID: 84867900061     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2012.08.116     Document Type: Article

References (34)

1. K. Corsi, F. Chellat, L. Yahia, and J.C. Fernandes Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles Biomaterials 24 2003 1255 1264
2. A. Fougerolles, H.P. Vornlocher, J. Maraganore, and J. Lieberman Interfering with disease: A progress report on siRNA-based therapeutics Nature Reviews: Drug Discovery 6 2007 443 453
3. S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, and K. Ueda Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery Journal of Biological Chemistry 276 2001 5836 5840
4. C. He, Y. Hu, L. Yin, C. Tang, and C. Yin Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles Biomaterials 31 2010 3657 3666
5. G.T. Hermanson Bioconjugate techniques (pp. 169-176) 1996 Academic Press San Diego
6. K.A. Howard, U.L. Rahbek, X.D. Liu, C.K. Damgaard, S.Z. Glud, and M.O. Andersen RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system Molecular Therapy 14 2006 476 484
7. R. Jayakumar, D. Menon, K. Manzoor, S.V. Nair, and H. Tamura Biomedical applications of chitin and chitosan based nanomaterials - A short review Carbohydrate Polymers 82 2010 227 232
8. A.M. Ji, D. Che, W.S. Li, L. Sun, Z.Y. Zhang, and B. Yang Functional gene silencing mediated by chitosan/siRNA nanocomplexes Nanotechnology 20 2009 405103
9. H. Katas, and H.O. Alpar Development and characterisation of chitosan nanoparticles for siRNA delivery Journal of Controlled Release 115 2006 216 225
10. S.W. Kim, N.Y. Kim, Y. Bin Choi, S.H. Park, J.M. Yang, and S. Shin RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system Journal of Controlled Release 143 2010 335 343
11. W.J. Kim, L.V. Christensen, S. Jo, J.W. Yockman, J.H. Jeong, and Y.H. Kim Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma Molecular Therapy 14 2006 343 350
12. P. Kumar, H.S. Ban, S.S. Kim, H.Q. Wu, T. Pearson, and D.L. Greiner T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice Cell 134 2008 577 586
13. K.Y. Lee Chitosan and its derivatives for gene delivery Macromolecular Research 15 2007 195 201
14. D.W. Lee, K.S. Yun, H.S. Ban, W.C. Choe, S.K. Lee, and K.Y. Lee Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery Journal of Controlled Release 139 2009 146 152
15. K.W. Leong, H.Q. Mao, V.L. Truong-Le, K. Roy, S.M. Walsh, and J.T. August DNA-polycation nanospheres as non-viral gene delivery vehicles Journal of Controlled Release 53 1998 183 193
16. S.-D. Li, and L. Huang Non-viral is superior to viral gene delivery Journal of Controlled Release 123 2007 181 183
17. L.X. Liu, Y.Y. Bai, C.N. Song, D.W. Zhu, L.P. Song, and H.L. Zhang The impact of arginine-modified chitosan-DNA nanoparticles on the function of macrophages Journal of Nanoparticle Research 12 2010 1637 1644
18. W.G. Liu, J.R. Zhang, Z.Q. Cao, F.Y. Xu, and K.D. Yao A chitosan-arginine conjugate as a novel anticoagulation biomaterial Journal of Materials Science Materials in Medicine 15 2004 1199 1203
19. K. Lundstrom Latest development in viral vectors for gene therapy Trends in Biotechnology 21 2003 117 122
20. H. Lv, S. Zhang, B. Wang, S. Cui, and J. Yan Toxicity of cationic lipids and cationic polymers in gene delivery Journal of Controlled Release 114 2006 100 109
21. S.R. Mao, W. Sun, and T. Kissel Chitosan-based formulations for delivery of DNA and siRNA Advanced Drug Delivery Reviews 62 2010 12 27
22. R.A.A. Muzzarelli, J. Boudrant, D. Meyer, N. Manno, M. DeMarchis, and M.G. Paoletti Current views on fungal chitin/chitosan, human chitinases, food preservation, glucans, pectins and inulin: A tribute to Henri Braconnot, precursor of the carbohydrate polymers science on the chitin bicentennial Carbohydrate Polymers 87 2012 995 1012
23. E.J. Nielsen, J.M. Nielsen, D. Becker, A. Karlas, H. Prakash, and S.Z. Glud Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticles Pharmaceutical Research 27 2010 2520 2527
24. S.M. Noh, M.O. Park, G. Shim, S.E. Han, H.Y. Lee, and J.H. Huh Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA Journal of Controlled Release 145 2010 159 164
25. T.G. Park, J.H. Jeong, and S.W. Kim Current status of polymeric gene delivery systems Advanced Drug Delivery Reviews 58 2006 467 486
26. C.V. Pecot, G.A. Calin, R.L. Coleman, G. Lopez-Berestein, and A.K. Sood RNA interference in the clinic: Challenges and future directions Nature Reviews Cancer 11 2011 59 67
27. R.H.A. Plasterk RNA silencing: The genome's immune system Science 296 2002 1263 1265
28. A. Santel, M. Aleku, O. Keil, J. Endruschat, V. Esche, and B. Durieux RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy Gene Therapy 13 2006 1360 1370
29. H. Sashiwa, and S.I. Aiba Chemically modified chitin and chitosan as biomaterials Progress in Polymer Science 29 2004 887 908
30. P.E. Saw, Y.T. Ko, and S. Jon Efficient liposomal nanocarrier-mediated oligodeoxynucleotide delivery involving dual use of a cell-penetrating peptide as a packaging and intracellular delivery agent Macromolecular Rapid Communications 31 2010 1155 1162
31. D. Schaffert, and E. Wagner Gene therapy progress and prospects: Synthetic polymer-based systems Gene Therapy 15 2008 1131 1138
32. P. Shankar, N. Manjunath, and J. Lieberman The prospect of silencing disease using RNA interference Journal of the American Medical Association 293 2005 1367 1373
33. B. Xiao, Y. Wan, M. Zhao, Y. Liu, and S. Zhang Preparation and characterization of antimicrobial chitosan-N-arginine with different degrees of substitution Carbohydrate Polymers 83 2011 144 150
34. H.L. Zhang, D.W. Zhu, L.P. Song, L.X. Liu, X. Dong, and Z.B. Liu Arginine conjugation affects the endocytic pathways of chitosan/DNA nanoparticles Journal of Biomedical Materials Research Part A 98A 2011 296 302